Colorectal Cancer and Small Bowel AdenocarcinomaPhase 1NCT07417488
Lm-GUCY2C vaccine
GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas
5 Phase 1 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Colorectal and anal5 studies
Colorectal Cancer and Small Bowel AdenocarcinomaPhase 1NCT07417488
GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas
Locally Advanced or Recurrent Colorectal CancerPhase 1/2NCT06307548
Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer
Colorectal CancerPhase 1/2NCT07411599
Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")
Colorectal Adenocarcinoma Planning SurgeryPhase 1NCT06225011
Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer
Locally Advanced Rectal AdenocarcinomaPhase 1NCT04808323
MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer